The effectiveness of matrix interventions in improving methadone treatment
- PMID: 24971256
- PMCID: PMC4070126
- DOI: 10.5812/ijhrba.8906
The effectiveness of matrix interventions in improving methadone treatment
Abstract
Background: The treatment of opioid dependence disorder is one of the major problems in medical centers around the world. Although MMT has been the major treatment in last few years in Iran, the existence of relapse before and after detoxification is still high. Methadone treatment has had a very low percentage of complete success.
Objectives: To evaluate the effectiveness of matrix group interventions in improving methadone treatment in the addicted was the main goal of this research.
Materials and methods: In a semi - experimental design, 24 male patients on the qualification cutoff score for the questionnaire survey (score less than 19 in depression test, and less than 21 in anxiety test) and the diagnosis of opioid dependence according to (DSM - IV) were substituted in two experimental and control groups randomly. At the beginning of the study, after the treatment period and in the follow-up phase (three months after the end of treatment), participants were evaluated by Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI) and the Anger Questionnaire (AQ), control group with no psychological treatment only took methadone. Data were analyzed using covariance analysis, chi square and Repeated Measures Analysis of Variance.
Results: Results showed that the effect of matrix group interventions on reducing relapse (P < 0.05), increasing the maintenance of treatment (P < 0.01), increasing the treatment compliance, reducing anger, anxiety and depression and methadone dose is more effective than methadone treatment (P < 0.05).
Conclusions: It seems matrix group interventions increase the effectiveness of methadone treatment by reducing the relapse prevention, the dose of methadone and remaining in treatment.
Keywords: Aggression; Anxiety; Depression; Matrix.
Similar articles
-
Investigating the effect of zinc supplementation on probability of relapse and mental health in patients with opioid use disorder undergoing methadone maintenance treatment.Subst Abuse Treat Prev Policy. 2023 Jan 6;18(1):1. doi: 10.1186/s13011-023-00514-5. Subst Abuse Treat Prev Policy. 2023. PMID: 36609286 Free PMC article. Clinical Trial.
-
Effectiveness of Low-Resolution Brain Electromagnetic Tomography Z Score Neurofeedback Comparison with Cognitive Rehabilitation in Depression and Anxiety in Opioid Use Disorder.Clin EEG Neurosci. 2024 Sep;55(5):553-560. doi: 10.1177/15500594241229194. Epub 2024 Feb 20. Clin EEG Neurosci. 2024. PMID: 38377950 Clinical Trial.
-
Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.JAMA. 2000 Mar 8;283(10):1303-10. doi: 10.1001/jama.283.10.1303. JAMA. 2000. PMID: 10714729 Clinical Trial.
-
Long-term detoxification of opioid use disorder with opium tincture assisted treatment.Front Psychiatry. 2023 Dec 7;14:1273587. doi: 10.3389/fpsyt.2023.1273587. eCollection 2023. Front Psychiatry. 2023. PMID: 38144477 Free PMC article.
-
Scopolamine detoxification technique for heroin dependence: a randomized trial.CNS Drugs. 2013 Dec;27(12):1093-102. doi: 10.1007/s40263-013-0111-9. CNS Drugs. 2013. PMID: 24092568 Clinical Trial.
Cited by
-
The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder.Subst Abuse Treat Prev Policy. 2020 Sep 25;15(1):72. doi: 10.1186/s13011-020-00317-y. Subst Abuse Treat Prev Policy. 2020. PMID: 32977820 Free PMC article.
-
Follow-Up of a Sample of Patients with Substance Use Disorder After Completing a Rehabilitation Program in a Continuous Care Unit in Eastern Province of Saudi Arabia, from 2012 to 2022: A Retrospective Study.Neuropsychiatr Dis Treat. 2024 Oct 9;20:1931-1939. doi: 10.2147/NDT.S473732. eCollection 2024. Neuropsychiatr Dis Treat. 2024. PMID: 39399881 Free PMC article.
-
Beyond methamphetamine: Documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting.Addict Behav. 2017 Mar;66:132-137. doi: 10.1016/j.addbeh.2016.11.014. Epub 2016 Nov 17. Addict Behav. 2017. PMID: 27940387 Free PMC article.
References
-
- Milby JB, Gurwitch RH, Wiebe DJ, Ling W, McLellan AT, Woody GE. Prevalence and diagnostic reliability of methadone maintenance detoxification fear. Am J Psychiatry. 1986;143(6):739–43. - PubMed
-
- Gerstein DR, Harwood HJ, Study CSAC, Medicine I. Treating Drug Problems: National Academies Press; 1990. - PubMed
-
- Stitzer ML, Iguchi MY, Kidorf M, Bigelow GE. Contingency management in methadone treatment: the case for positive incentives. NIDA Res Monogr. 1993;137:19–36. - PubMed
-
- McAuliffe WE. A randomized controlled trial of recovery training and self-help for opioid addicts in New England and Hong Kong. J Psychoactive Drugs. 1990;22(2):197–209. - PubMed
LinkOut - more resources
Full Text Sources